Inventor · disambiguated record
Walter J. Storkus
Also filed as: STORKUS WALTER · STORKUS WALTER J
16 granted patents·7 pending applications·189 citations·filing 1995–2023
93Inventor score
Files withUNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION6UNIV PITTSBURGH5INTREXON CORP2STORKUS WALTER J2UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION2
Top patents by PatentIndex Score
23 records- 0195US7297337B2EphA2 T-cell epitopes and uses thereforMEDIMMUNE INC·Filed 2005·Granted Nov 20, 2007·26 cites·45 claims
- 0291US7612162B2Peptide analogs capable of enhancing stimulation of a glioma-specific CTL responseUNIV PITTSBURGH·Filed 2005·Granted Nov 3, 2009·20 cites·10 claims
- 0390US8114407B2EphA2 T-cell epitopes and uses thereforSTORKUS WALTER J·Filed 2007·Granted Feb 14, 2012·12 cites·9 claims
- 0487US2024101625A1Epha2 t-cell epitope agonists and uses thereforeUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2023·Application pending·0 cites
- 0585US6077519AMethods for isolation and use of T cell epitopes eluted from viable cells in vaccines for treating cancer patientsUNIV PITTSBURGH·Filed 1997·Granted Jun 20, 2000·76 cites·24 claims
- 0684US10434155B2Peptide analogs capable of enhancing stimulation of a glioma-specific CTL responseUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2016·Granted Oct 8, 2019·3 cites·12 claims
- 0783US8859488B2Peptide analogs capable of enhancing stimulation of a glioma-specific CTL responseOKADA HIDEHO·Filed 2009·Granted Oct 14, 2014·5 cites·14 claims
- 0883US2024252608A1Peptide analogs capable of enhancing stimulation of a glioma-specific ctl responseUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2023·Application pending·0 cites
- 0980US8574584B2EphA2 T cell epitopes and uses thereforSTORKUS WALTER J·Filed 2012·Granted Nov 5, 2013·3 cites·10 claims
- 1078US11723963B2Peptide analogs capable of enhancing stimulation of a glioma-specific CTL responseUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2019·Granted Aug 15, 2023·0 cites·8 claims
- 1177US9675642B2Engineered dendritic cells and uses for the treatment of cancerINTREXON CORP·Filed 2013·Granted Jun 13, 2017·3 cites·7 claims
- 1276US11787846B2EphA2 T-cell epitope agonists and uses thereforeUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2020·Granted Oct 17, 2023·0 cites·22 claims
- 1376US10781240B2EPHA2 t-cell epitope agonists and uses thereforeUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2018·Granted Sep 22, 2020·0 cites·18 claims
- 1473US5989565AElution and identification of T cell epitopes from viable cellsUNIV PITTSBURGH·Filed 1995·Granted Nov 23, 1999·41 cites·7 claims
- 1570US9359402B2EphA2 T-cell epitope agonists and uses thereforeUNIV PITTSBURGH— OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2013·Granted Jun 7, 2016·0 cites·12 claims
- 1664US10131699B2EphA2 T-cell epitope agonists and uses thereforeUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2016·Granted Nov 20, 2018·0 cites·6 claims
- 1761US2009123441A1Engineered Dendritic Cells and Uses for the Treatment of CancerUNIV PITTSBURGH OF COMMONWEALT·Filed 2008·Application pending·0 cites
- 1856US2017312315A1Engineered Dendritic Cells and Uses for the Treatment of CancerINTREXON CORP·Filed 2017·Application pending·0 cites
- 1955US9345770B2Immunogenic tumor associated stromal cell antigen peptides and methods of their useUNIV PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2012·Granted May 24, 2016·0 cites·17 claims
- 2054US2005048550A1EphA2 T-cell epitope agonists and uses thereforUNIV PITTSBURGH·Filed 2004·Application pending·0 cites
- 2151US2012114620A1Engineered Dendritic Cells and Uses for the Treatment of CancerBRAUGHLER J MARK·Filed 2011·Application pending·0 cites
- 2249US9937250B2Immunogenic tumor associated stromal cell antigen peptides and methods of their useUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2016·Granted Apr 10, 2018·0 cites·12 claims
- 2343US2005170503A1In vitro induction of antigen-specific T-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogensUNIV PITTSBURGH·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Walter J. Storkus files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →